ADmit Therapeutics

Overview

ADmit Therapeutics is a Spanish biotech company focused on early diagnosis solutions for Alzheimer’s disease and other neurodegenerative disorders. The company develops blood-based diagnostic technologies using biomarkers and AI-driven analysis to improve early detection and treatment outcomes.

Key Facts

Sector

Healthcare

Business model

Services

Stage

Growth

Team size

1-10

Focus Areas